» Articles » PMID: 31203442

Human Cytomegalovirus Infection is Correlated with Enhanced Cyclooxygenase-2 and 5-lipoxygenase Protein Expression in Breast Cancer

Overview
Specialty Oncology
Date 2019 Jun 17
PMID 31203442
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: While enhanced expression of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) and their derived metabolites is associated with breast cancer (BC) risk, the precise link between BC carcinogenesis and enhanced inflammatory activity remains to be clarified. Human Cytomegalovirus (HCMV) may induce expression of COX-2 and 5-LO and is frequently found in breast cancer biopsies. Thus, we investigated whether there is an association between HCMV proteins and expression of COX-2 and 5-LO in human BC tissue and BC cell lines.

Materials And Methods: Paraffin embedded biopsies obtained from 49 patients with breast cancer and 26 tissue samples from adjacent, benign breast tissues were retrospectively examined for HCMV-immediate early (IE), HCMV-Late (LA), COX-2, and 5-LO proteins by immunohistochemistry. In vitro, uninfected and HCMV-infected BC cell lines were examined for COX-2 and 5-LO transcripts and proteins by PCR and flow cytometry.

Results: Extensive expression of COX-2, 5-LO and HCMV-IE proteins were preferentially detected in BC samples. We found a statistically significant concordant correlation between extensive HCMV-IE and COX-2 (P < 0.0001) as well as with HCMV-IE and 5-LO (P = 0.0003) in infiltrating BC. In vitro, HCMV infection induced COX-2 and 5-LO transcripts and COX-2 proteins in MCF-7 cells (P =0.008, P =0.018, respectively). In MDA-MB-231 cells that already had high base line levels of COX-2 expression, HCMV induced both COX-2 and 5-LO proteins but not transcripts.

Conclusion: Our findings demonstrate a significant correlation between extensive HCMV-IE protein expression and overexpression of COX-2 and 5-LO in human breast cancer.

Citing Articles

Human Cytomegalovirus Infection and Breast Cancer: A Literature Review of Clinical and Experimental Data.

Blanco R, Munoz J Biology (Basel). 2025; 14(2).

PMID: 40001942 PMC: 11851556. DOI: 10.3390/biology14020174.


Pattern of Expression of Genes Involved in Systemic Inflammation and Glutathione Metabolism Reveals Exacerbation of COPD.

Oit-Wiscombe I, Virag L, Kilk K, Soomets U, Altraja A Antioxidants (Basel). 2024; 13(8).

PMID: 39199199 PMC: 11351727. DOI: 10.3390/antiox13080953.


The Role of Oncogenic Viruses in the Pathogenesis of Sporadic Breast Cancer: A Comprehensive Review of the Current Literature.

Rossi C, Inzani F, Cesari S, Rizzo G, Paulli M, Pedrazzoli P Pathogens. 2024; 13(6).

PMID: 38921749 PMC: 11206847. DOI: 10.3390/pathogens13060451.


Antioxidant Glutathione Analogues UPF1 and UPF17 Modulate the Expression of Enzymes Involved in the Pathophysiology of Chronic Obstructive Pulmonary Disease.

Oit-Wiscombe I, Soomets U, Altraja A Curr Issues Mol Biol. 2024; 46(3):2343-2354.

PMID: 38534765 PMC: 10969540. DOI: 10.3390/cimb46030149.


Targeting Breast Cancer with N-Acetyl-D-Glucosamine: Integrating Machine Learning and Cellular Assays for Promising Results.

Baysal O, Genc D, Silme R, Kirboga K, Coban D, Abdul Ghafoor N Anticancer Agents Med Chem. 2024; 24(5):334-347.

PMID: 38305389 DOI: 10.2174/0118715206270568231129054853.


References
1.
Steele V, Holmes C, Hawk E, Kopelovich L, Lubet R, Crowell J . Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev. 1999; 8(5):467-83. View

2.
Kotenko S, Saccani S, Izotova L, Mirochnitchenko O, Pestka S . Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A. 2000; 97(4):1695-700. PMC: 26498. DOI: 10.1073/pnas.97.4.1695. View

3.
Avis I, Hong S, Martinez A, Moody T, Choi Y, Trepel J . Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J. 2001; 15(11):2007-9. DOI: 10.1096/fj.00-0866fje. View

4.
Zhu H, Cong J, Yu D, Bresnahan W, Shenk T . Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci U S A. 2002; 99(6):3932-7. PMC: 122626. DOI: 10.1073/pnas.052713799. View

5.
Xu X . COX-2 inhibitors in cancer treatment and prevention, a recent development. Anticancer Drugs. 2002; 13(2):127-37. DOI: 10.1097/00001813-200202000-00003. View